Showing 25 to 36 of 37 results
Trump's EPA Nominee to Review, Potentially Reclaim, IRA Climate Funds
President-elect Trump's EPA nominee, Lee Zeldin, committed to reviewing and potentially reclaiming funds from the Inflation Reduction Act (IRA) during Senate testimony, citing accountability concerns raised by Senator Ricketts, who noted insufficient oversight funding for the EPA inspector general. ...
Trump's EPA Nominee to Review, Potentially Reclaim, IRA Climate Funds
President-elect Trump's EPA nominee, Lee Zeldin, committed to reviewing and potentially reclaiming funds from the Inflation Reduction Act (IRA) during Senate testimony, citing accountability concerns raised by Senator Ricketts, who noted insufficient oversight funding for the EPA inspector general. ...
Progress
44% Bias Score
IRS Improves Taxpayer Service Despite Backlogs, Budget Threats
The IRS has improved taxpayer services thanks to the Inflation Reduction Act, but still faces significant backlogs in identity theft (22-month delays) and ERC claims (1.2 million pending), impacting taxpayers and businesses; budget cuts threaten further progress.
IRS Improves Taxpayer Service Despite Backlogs, Budget Threats
The IRS has improved taxpayer services thanks to the Inflation Reduction Act, but still faces significant backlogs in identity theft (22-month delays) and ERC claims (1.2 million pending), impacting taxpayers and businesses; budget cuts threaten further progress.
Progress
40% Bias Score
Social Security, Medicare Changes for 2025
In 2025, Social Security recipients will see a 2.5% cost of living increase, while some public pensioners will receive additional benefits due to the Social Security Fairness Act eliminating the Windfall Elimination Provision and Government Pension Offset. Medicare Part D will have a $2,000 annual o...
Social Security, Medicare Changes for 2025
In 2025, Social Security recipients will see a 2.5% cost of living increase, while some public pensioners will receive additional benefits due to the Social Security Fairness Act eliminating the Windfall Elimination Provision and Government Pension Offset. Medicare Part D will have a $2,000 annual o...
Progress
40% Bias Score
Medicare Drug Cost Cap Set at $2,000 Annually Starting in 2025
The Inflation Reduction Act of 2022 caps out-of-pocket Medicare Part D prescription drug costs at $2,000 annually starting in 2025, benefiting over 3 million enrollees initially, rising to over 4 million by 2029, with roughly 40% seeing annual savings of at least $1,000; insurers received roughly $5...
Medicare Drug Cost Cap Set at $2,000 Annually Starting in 2025
The Inflation Reduction Act of 2022 caps out-of-pocket Medicare Part D prescription drug costs at $2,000 annually starting in 2025, benefiting over 3 million enrollees initially, rising to over 4 million by 2029, with roughly 40% seeing annual savings of at least $1,000; insurers received roughly $5...
Progress
36% Bias Score
IRA Offers $8.8 Billion for Home Energy Rebates to Cut Utility Costs
The Inflation Reduction Act allocates $8.8 billion in home energy rebates and tax credits to improve energy efficiency, potentially saving homeowners up to $8,000 on upgrades and reducing carbon emissions by addressing energy waste in older homes.
IRA Offers $8.8 Billion for Home Energy Rebates to Cut Utility Costs
The Inflation Reduction Act allocates $8.8 billion in home energy rebates and tax credits to improve energy efficiency, potentially saving homeowners up to $8,000 on upgrades and reducing carbon emissions by addressing energy waste in older homes.
Progress
40% Bias Score
Pharmaceutical Industry Faces 2025 Inflection Point Amidst Global Cost Pressures
Global pharmaceutical manufacturers face increasing pressure to lower drug prices in 2025 due to government regulations (e.g., the Inflation Reduction Act), payer consolidation, and consumer cost concerns; requiring manufacturers to prioritize long-term value, evidence-based decision-making, and str...
Pharmaceutical Industry Faces 2025 Inflection Point Amidst Global Cost Pressures
Global pharmaceutical manufacturers face increasing pressure to lower drug prices in 2025 due to government regulations (e.g., the Inflation Reduction Act), payer consolidation, and consumer cost concerns; requiring manufacturers to prioritize long-term value, evidence-based decision-making, and str...
Progress
44% Bias Score
Future of Medicare Drug Price Negotiations Uncertain Under Trump
Medicare's new drug price negotiation program, enacted under the Inflation Reduction Act, faces an uncertain future under the incoming Trump administration; while it lowered prices on 10 drugs in 2023, and aims to lower prices on 15 more in 2027, Republican efforts to repeal it are underway.
Future of Medicare Drug Price Negotiations Uncertain Under Trump
Medicare's new drug price negotiation program, enacted under the Inflation Reduction Act, faces an uncertain future under the incoming Trump administration; while it lowered prices on 10 drugs in 2023, and aims to lower prices on 15 more in 2027, Republican efforts to repeal it are underway.
Progress
52% Bias Score
IRS Watchdog Urges Congress to Preserve Taxpayer Services Funding
The IRS's internal watchdog warned Congress against cutting funding for taxpayer services and technology modernization, highlighting an imbalance in the Inflation Reduction Act's funding allocation where only 10% was allocated to these crucial areas compared to 58% for enforcement, despite 98% of fe...
IRS Watchdog Urges Congress to Preserve Taxpayer Services Funding
The IRS's internal watchdog warned Congress against cutting funding for taxpayer services and technology modernization, highlighting an imbalance in the Inflation Reduction Act's funding allocation where only 10% was allocated to these crucial areas compared to 58% for enforcement, despite 98% of fe...
Progress
36% Bias Score
New State Laws Take Effect in 2025: Minimum Wage Hikes, Healthcare Restrictions, and Medicare Changes
On January 1, 2025, new laws in several states increased minimum wages, with Washington's reaching $16.66, and Minnesota's implementing a $11.13 standard for all employers; New Hampshire banned gender-affirming surgeries for minors; New York constitutionally protected abortion rights; and Medicare b...
New State Laws Take Effect in 2025: Minimum Wage Hikes, Healthcare Restrictions, and Medicare Changes
On January 1, 2025, new laws in several states increased minimum wages, with Washington's reaching $16.66, and Minnesota's implementing a $11.13 standard for all employers; New Hampshire banned gender-affirming surgeries for minors; New York constitutionally protected abortion rights; and Medicare b...
Progress
44% Bias Score
Medicare Part D Drug Cost Cap Set at $2,000 Annually Starting in 2025
The Inflation Reduction Act institutes a $2,000 annual out-of-pocket cap on Medicare Part D prescription drug costs starting in 2025, benefiting over 3 million enrollees without low-income subsidies, with this number projected to reach over 4 million by 2029; insurers will cover 60% of costs in the ...
Medicare Part D Drug Cost Cap Set at $2,000 Annually Starting in 2025
The Inflation Reduction Act institutes a $2,000 annual out-of-pocket cap on Medicare Part D prescription drug costs starting in 2025, benefiting over 3 million enrollees without low-income subsidies, with this number projected to reach over 4 million by 2029; insurers will cover 60% of costs in the ...
Progress
48% Bias Score
Medicare Caps Annual Out-of-Pocket Prescription Drug Costs at $2,000
Starting January 1, 2025, Medicare will cap annual out-of-pocket prescription drug costs at $2,000 for its 65 million enrollees, a move expected to significantly aid cancer patients and other older adults facing high medication expenses, particularly those on fixed incomes.
Medicare Caps Annual Out-of-Pocket Prescription Drug Costs at $2,000
Starting January 1, 2025, Medicare will cap annual out-of-pocket prescription drug costs at $2,000 for its 65 million enrollees, a move expected to significantly aid cancer patients and other older adults facing high medication expenses, particularly those on fixed incomes.
Progress
36% Bias Score
Pfizer's 2025 Forecast Meets Expectations Amidst Medicare Changes and Investor Scrutiny
Pfizer projects 2025 profits near analyst estimates, anticipating stable Covid-19 product sales despite a \$1 billion revenue reduction from Medicare changes and ongoing investor pressure following a 12% share decline this year.
Pfizer's 2025 Forecast Meets Expectations Amidst Medicare Changes and Investor Scrutiny
Pfizer projects 2025 profits near analyst estimates, anticipating stable Covid-19 product sales despite a \$1 billion revenue reduction from Medicare changes and ongoing investor pressure following a 12% share decline this year.
Progress
36% Bias Score
Showing 25 to 36 of 37 results